U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07438496) titled 'A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus' on Feb. 23.
Brief Summary: The purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term disease where the immune system mistakenly attacks its own healthy tissues, causing swelling and redness in various organs).
Study Start Date: April 03
Study Type: INTERVENTIONAL
Condition:
Lupus Erythematosus, Systemic
Intervention:
DRUG: Nipocalimab
Nipocalimab will be administered.
DRUG: Placebo
Placebo will be administered.
DRUG: St...